Dr. Jeffrey A. Zonder
Claim this profileBarbara Ann Karmanos Cancer Institute
Area of expertise
Multiple Myeloma
Jeffrey A. Zonder has run 9 trials for Multiple Myeloma. Some of their research focus areas include:
Amyloidosis
Jeffrey A. Zonder has run 3 trials for Amyloidosis. Some of their research focus areas include:
Affiliated Hospitals
Barbara Ann Karmanos Cancer Institute
Karmanos Cancer Institute
Clinical Trials Jeffrey A. Zonder is currently running
REGN5458
for Multiple Myeloma
The main purpose of this study is to learn about the safety of linvoseltamab and to find out what is the best dose of linvoseltamab to give to patients with multiple myeloma and to look for any signs that linvoseltamab can effectively treat cancer. The study is looking at several other research questions, including: * Side effects that may be experienced by people receiving linvoseltamab * How linvoseltamab works in the body * How much linvoseltamab is present in the blood * How linvoseltamab may work to treat cancer
Recruiting
1 award
Phase 1 & 2
Leflunomide
for High-Risk Smoldering Multiple Myeloma
This phase II trial studies the effects of leflunomide in treating African-American and European-American patients with high-risk smoldering multiple myeloma. Leflunomide is used to decrease the body's immune response and may delay the symptoms of multiple myeloma in patients of African-American and European decent.
Recruiting
1 award
Phase 2
23 criteria
More about Jeffrey A. Zonder
Clinical Trial Related
6 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Jeffrey A. Zonder has experience with
- Isatuximab
- Daratumumab
- Belantamab Mafodotin
- Selinexor
- Tracking Dietary/Supplement Intake On MyFitnessPal Smartphone Application (app)
- Dexamethasone
Breakdown of trials Jeffrey A. Zonder has run
Multiple Myeloma
Relapse
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey A. Zonder specialize in?
Jeffrey A. Zonder focuses on Multiple Myeloma and Amyloidosis. In particular, much of their work with Multiple Myeloma has involved MMRF002 patients, or patients who are early stage.
Is Jeffrey A. Zonder currently recruiting for clinical trials?
Yes, Jeffrey A. Zonder is currently recruiting for 3 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey A. Zonder has studied deeply?
Yes, Jeffrey A. Zonder has studied treatments such as Isatuximab, Daratumumab, Belantamab mafodotin.
What is the best way to schedule an appointment with Jeffrey A. Zonder?
Apply for one of the trials that Jeffrey A. Zonder is conducting.
What is the office address of Jeffrey A. Zonder?
The office of Jeffrey A. Zonder is located at: Barbara Ann Karmanos Cancer Institute, Detroit, Michigan 48201 United States. This is the address for their practice at the Barbara Ann Karmanos Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.